Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine

Journal of the American College of Cardiology

Volumn 32, Issue 7, 1998, Pages 1969-1974

  Caramori, Paulo R A ^a   Adelman, Allan G ^a   Azevedo, Eduardo R ^a   Newton, Gary E ^a   Parker, Andrea B ^b   Parker, John D ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b SOCAR Cardiac Research   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ALPHA TOCOPHEROL; GLYCERYL TRINITRATE; RETINOL;

ADULT; ANGIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY CONSTRICTION; DIAGNOSTIC VALUE; DRUG TOLERANCE; ELECTROCARDIOGRAM; FEMALE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MYOCARDIAL DISEASE; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; RISK FACTOR; STATISTICAL ANALYSIS; TRANSDERMAL DRUG ADMINISTRATION; VASODILATATION; VASOMOTOR REFLEX; VITAMIN SUPPLEMENTATION;

ACETYLCHOLINE; ADULT; AGED; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; NITROGLYCERIN; VASOCONSTRICTION; VASODILATOR AGENTS;

EID: 0032420985     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00456-2     Document Type: Article

References (35)

1. Packer M. What causes tolerance to nitroglycerine? The 100-year-old mystery continues. J Am Coll Cardiol. 16:1990;932-935.
2. Elkayam U. Tolerance to organic nitrates evidence, mechanisms, clinical relevance, and strategies for prevention . Ann Intern Med. 114:1991;667-677.
3. Rydell E.L., Axelsson K.L. Adrenaline toxicity in mice sensitization of alpha 1 adrenoreceptors by nitroglycerin . Acta Pharmacol Toxicol (Copenh). 55:1984;73-77.
4. Münzel T., Giaid A., Kurz S., Stewart D.J., Harrison D.G. Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc Natl Acad Sci USA. 92:1995;5244-5248.
5. Münzel T., Sayegh H., Freeman B.A., Tarpey M.M., Harrison D.G. Evidence for enhanced vascular superoxide anion production in nitrate tolerance a novel mechanism underlying tolerance and cross-tolerance . J Clin Invest. 95:1995;187-194.
6. Heitzer T., Just H., Carsten B., Meinertz T., Olschewski M., Münzel T. Long-term nitroglycerin treatment is associated with supersensitivity to vasoconstricotrs in men with stable coronary artery disease prevention by concomitant treatment with captopril . J Am Coll Cardiol. 31:1998;83-88.
7. Lange R.L., Reid M.S., Tresch D.D., Keelan M.H., Bernhard V.M., Coolidge G. Nonatheromatous ischemic heart disease following withdrawal from chronic industrial nitroglycerin exposure. Circulation. 66:1972;666-678.
8. Morton W.E. Occupational habituation to aliphatic nitrates and the withdrawal hazards of coronary disease and hypertension. J Occup Med. 19:1977;197-200.
9. DeMots H., Glasser S.P. Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina. J Am Coll Card. 13:1989;786-788.
10. Ferratini M., Pirelli S., Merlini P., Silva P., Pollavini G. Intermittent transdermal nitroglycerin monotherapy in stable exercise-induced angina a comparison with a continuous schedule . Eur Heart J. 10:1989;998-1002.
11. Ferratini M. Risk of rebound phenomenon during nitrate withdrawal. Int J Cardiol. 45:1994;89-96.
12. Adelman A.G., Cohen E.A., Kimball B.P., et al. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med. 329:1993;228-233.
13. Ludmer P.L., Selwyn A.P., Shook T.L., et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 315:1986;1046-1051.
14. Yeung A.C., Vekshtein V.I., Krantz D.S., et al. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med. 325:1991;1551-1556.
15. Treasure C.B., Vita J.A., Cox D.A., et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 81:1990;772-779.
16. Treasure C.B., Manoukian S.V., Klein J.L., et al. Epicardial coronary artery responses to acetylcholine are impaired in hypertensive patients. Circ Res. 71:1992;776-781.
17. Anderson T.J., Meredith I.T., Yeung A.C., Frei B., Selwyn A.P., Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 332:1995;488-493.
18. Treasure C.B., Klein J.L., Weintraub W.S., et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 332:1995;481-487.
19. Makimattila S., Virkamaki A., Groop P.H., et al. Chronic hyperglycemia impairs endothelial function and insulin sensitivity via different mechanisms in insulin-dependent diabetes mellitus. Circulation. 94:1996;1276-1282.
20. Drexler H. Endothelial dysfunction clinical implications . Prog Cardiovasc Dis. 39:1997;287-324.
21. Vita J.A., Treasure C.B., Nabel E.G., et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 81:1990;491-497.
22. Lerman A., Holmes D.R. Jr, Bell M.R., Garratt K.N., Nishimura R.A., Burnett J.C. Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation. 92:1995;2426-2431.
23. Parker J.D., Parker A.B., Farrell B., Parker J.O. Intermittent transdermal nitroglycerin therapy decreased anginal threshold during the nitrate-free interval . Circulation. 91:1995;973-978.
24. Parker J.O., Amies M.H., Hawkinson R.W., et al. Intermittent transdermal nitroglycerin therapy in angina pectoris: clinically effective without tolerance or rebound. Minitran Efficacy Study Group. Circulation. 91:1995;1368-1374.
25. Stewart D.J., Holtz J., Bassenge E. Long-term nitroglycerin treatment effect on direct and endothelium-mediated large coronary artery dilation in conscious dogs . Circulation. 75:1987;847-856.
26. Münzel T., Holtz J., Mulsch A., Stewart D.J., Bassenge E. Nitrate tolerance in epicardial arteries or in the venous system is not reversed by N-acetylcysteine in vivo, but tolerance-independent interactions exist. Circulation. 79:1989;188-197.
27. Münzel T., Bassenge E. Long-term angiotensin-converting enzyme inhibition with high-dose enalapril retards nitrate tolerance in large epicardial arteries and prevents rebound coronary vasoconstriction in vivo. Circulation. 93:1996;2052-2058.
28. Kai H., Yamamoto H., Noma M., et al. Effects of continuous intravenous infusion of isosorbide dinitrate on development of tolerance to vasodilating action in human epicardial coronary arteries. Am Heart J. 128:1994;230-236.
29. Münzel T., Heitzer T., Kurz S., et al. Dissociation of coronary vascular tolerance and neurohormonal adjustments during long-term nitroglycerin therapy in patients with stable coronary artery disease. J Am Coll Cardiol. 27:1996;297-303.
30. Brown J.B. The crossover experiment for clinical trials. Biometrics. 36:1980;69-79.
31. Mancini G.B., Henry G.C., Macaya C., et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease the TREND (Trial on Reversing ENdothelial Dysfunction) Study . Circulation. 94:1996;258-265.
32. Schwarz M., Katz S.D., Demopoulos L., et al. Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure. Circulation. 89:1994;1609-1614.
33. Ting H.H., Timimi F.K., Boles K.S., Creager S.J., Ganz P., Creager M.A. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 97:1996;22-28.
34. Levine G.N., Frei B., Koulouris S.N., Gerhard M.D., Keaney J.F. Jr, Vita J.A. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 93:1996;1107-1113.
35. Ting H., Timimi F., Haley E., Roddy M., Ganz P., Creager M. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation. 95:1997;2617-2622.